ScinoPharm Taiwan, Ltd.

TWSE:1789 Stock Report

Market Cap: NT$22.9b

ScinoPharm Taiwan Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Susan Lu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.4yrs
CEO ownershipn/a
Management average tenure3.8yrs
Board average tenure6.4yrs

Recent management updates

Recent updates

ScinoPharm Taiwan's (TWSE:1789) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 17
ScinoPharm Taiwan's (TWSE:1789) Shareholders Will Receive A Smaller Dividend Than Last Year

Investors In ScinoPharm Taiwan, Ltd. (TPE:1789) Should Consider This, First

Apr 04
Investors In ScinoPharm Taiwan, Ltd. (TPE:1789) Should Consider This, First

A Look At The Intrinsic Value Of ScinoPharm Taiwan, Ltd. (TPE:1789)

Mar 14
A Look At The Intrinsic Value Of ScinoPharm Taiwan, Ltd. (TPE:1789)

Weak Financial Prospects Seem To Be Dragging Down ScinoPharm Taiwan, Ltd. (TPE:1789) Stock

Feb 21
Weak Financial Prospects Seem To Be Dragging Down ScinoPharm Taiwan, Ltd. (TPE:1789) Stock

ScinoPharm Taiwan's (TPE:1789) Shareholders Are Down 45% On Their Shares

Jan 25
ScinoPharm Taiwan's (TPE:1789) Shareholders Are Down 45% On Their Shares

We Think ScinoPharm Taiwan (TPE:1789) Can Manage Its Debt With Ease

Jan 04
We Think ScinoPharm Taiwan (TPE:1789) Can Manage Its Debt With Ease

Estimating The Intrinsic Value Of ScinoPharm Taiwan, Ltd. (TPE:1789)

Dec 14
Estimating The Intrinsic Value Of ScinoPharm Taiwan, Ltd. (TPE:1789)

Are Poor Financial Prospects Dragging Down ScinoPharm Taiwan, Ltd. (TPE:1789 Stock?

Nov 23
Are Poor Financial Prospects Dragging Down ScinoPharm Taiwan, Ltd. (TPE:1789 Stock?

CEO

Susan Lu

3.4yrs

Tenure

Ms. Li-An Lu, also known as Susan, is Director of SciAnda (Changshu) Pharmaceutical, Ltd. from June 14, 2024. She serves as President and Chief Executive Officer at ScinoPharm Taiwan, Ltd.since 2021. She...


Leadership Team

NamePositionTenureCompensationOwnership
Chih-Hsien Lo
Chairman & General Chief Strategy Officer13.9yrsno datano data
Li-An Lu
President & CEO3.4yrsno datano data
Chih-Hui Lin
Acting Financial Off.14yrsno datano data
Ling-Hsiao Lien
Vice-President of Marketing3.8yrsno datano data
Li-Chiao Chang
VP of R&D Division and Chief Scientific Officerno datano data0%
NT$ 0
Jason Chen
Director of Human Resources & Admin3yrsno datano data
Shun Yang Lin
Director of Corporate Developmentno datano datano data

3.8yrs

Average Tenure

Experienced Management: 1789's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Chih-Hsien Lo
Chairman & General Chief Strategy Officer13.9yrsno datano data
Po-Ming Hou
Representative Director7.6yrsno datano data
Fu-Jung Lai
Representative Director5.7yrsno datano data
Shiow-Ling Kao
Representative Director13.9yrsno datano data
Chiou-Ru Shih
Representative Director13.9yrsno datano data
Tsung-Ping Wu
Representative Director9yrsno datano data
Jia-Horng Guo
Representative Director6.8yrsno datano data
Li-Tzong Chen
Independent Director6yrsno datano data
Ming-Chuan Hsieh
Representative Director6yrsno datano data
Ya-Po Yang
Representative Director6yrsno datano data
Wen-Chang Chang
Independent Director6yrsno datano data
Lewis Lee
Independent Director3.4yrsno datano data

6.4yrs

Average Tenure

Experienced Board: 1789's board of directors are considered experienced (6.4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.